149 related articles for article (PubMed ID: 20625128)
1. Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study.
Mauz-Körholz C; Hasenclever D; Dörffel W; Ruschke K; Pelz T; Voigt A; Stiefel M; Winkler M; Vilser C; Dieckmann K; Karlén J; Bergsträsser E; Fosså A; Mann G; Hummel M; Klapper W; Stein H; Vordermark D; Kluge R; Körholz D
J Clin Oncol; 2010 Aug; 28(23):3680-6. PubMed ID: 20625128
[TBL] [Abstract][Full Text] [Related]
2. Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial.
Mauz-Körholz C; Landman-Parker J; Balwierz W; Ammann RA; Anderson RA; Attarbaschi A; Bartelt JM; Beishuizen A; Boudjemaa S; Cepelova M; Claviez A; Daw S; Dieckmann K; Fernández-Teijeiro A; Fosså A; Gattenlöhner S; Georgi T; Hjalgrim LL; Hraskova A; Karlén J; Kluge R; Kurch L; Leblanc T; Mann G; Montravers F; Pears J; Pelz T; Rajić V; Ramsay AD; Stoevesandt D; Uyttebroeck A; Vordermark D; Körholz D; Hasenclever D; Wallace WH
Lancet Oncol; 2022 Jan; 23(1):125-137. PubMed ID: 34895479
[TBL] [Abstract][Full Text] [Related]
3. Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study.
Mauz-Körholz C; Landman-Parker J; Fernández-Teijeiro A; Attarbaschi A; Balwierz W; Bartelt JM; Beishuizen A; Boudjemaa S; Cepelova M; Ceppi F; Claviez A; Daw S; Dieckmann K; Fosså A; Gattenlöhner S; Georgi T; Hjalgrim LL; Hraskova A; Karlén J; Kurch L; Leblanc T; Mann G; Montravers F; Pears J; Pelz T; Rajić V; Ramsay AD; Stoevesandt D; Uyttebroeck A; Vordermark D; Körholz D; Hasenclever D; Wallace WH; Kluge R
Lancet Oncol; 2023 Mar; 24(3):252-261. PubMed ID: 36858722
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics of the patients with Hodgkin's lymphoma involving extranodal sites.
Li ZM; Zhu YJ; Xia Y; Huang JJ; Jiang WQ
Chin J Cancer; 2012 Jul; 31(7):342-7. PubMed ID: 22692069
[TBL] [Abstract][Full Text] [Related]
5. A case report of Hodgkin lymphoma in a patient treated with ustekinumab for psoriasis.
Charakopoulos E; Spyrou I; Viniou NA; Giannakopoulou N; Hatzidavid S; Diamantopoulos PT
Medicine (Baltimore); 2020 May; 99(21):e20048. PubMed ID: 32481271
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary lesions in early response assessment in pediatric Hodgkin lymphoma: prevalence and possible implications for initial staging.
Stoevesandt D; Ludwig C; Mauz-Körholz C; Körholz D; Hasenclever D; McCarten K; Flerlage JE; Kurch L; Wohlgemuth WA; Landman-Parker J; Wallace WH; Fosså A; Vordermark D; Karlén J; Cepelová M; Klekawka T; Attarbaschi A; Hraskova A; Uyttebroeck A; Beishuizen A; Dieckmann K; Leblanc T; Daw S; Steglich J
Pediatr Radiol; 2024 May; 54(5):725-736. PubMed ID: 38296856
[TBL] [Abstract][Full Text] [Related]
7. Vincristine in Combination Therapy of Cancer: Emerging Trends in Clinics.
Škubník J; Pavlíčková VS; Ruml T; Rimpelová S
Biology (Basel); 2021 Aug; 10(9):. PubMed ID: 34571726
[TBL] [Abstract][Full Text] [Related]
8. Pediatric Hodgkin Lymphoma: on the road to a 'radiotherapy-free' cure rate?-Commentary on a report on final results of the Multinational Trial GPOH-HD95.
Corazzelli G
Transl Pediatr; 2013 Jul; 2(3):120-3. PubMed ID: 26835302
[No Abstract] [Full Text] [Related]
9. Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031.
Friedman DL; Chen L; Wolden S; Buxton A; McCarten K; FitzGerald TJ; Kessel S; De Alarcon PA; Chen AR; Kobrinsky N; Ehrlich P; Hutchison RE; Constine LS; Schwartz CL
J Clin Oncol; 2014 Nov; 32(32):3651-8. PubMed ID: 25311218
[TBL] [Abstract][Full Text] [Related]
10. BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group.
Kelly KM; Sposto R; Hutchinson R; Massey V; McCarten K; Perkins S; Lones M; Villaluna D; Weiner M
Blood; 2011 Mar; 117(9):2596-603. PubMed ID: 21079154
[TBL] [Abstract][Full Text] [Related]
11. Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95.
Dörffel W; Rühl U; Lüders H; Claviez A; Albrecht M; Bökkerink J; Holte H; Karlen J; Mann G; Marciniak H; Niggli F; Schmiegelow K; Schwarze EW; Pötter R; Wickmann L; Schellong G
J Clin Oncol; 2013 Apr; 31(12):1562-8. PubMed ID: 23509321
[TBL] [Abstract][Full Text] [Related]
12. Pediatric Hodgkin Lymphoma.
Mauz-Körholz C; Metzger ML; Kelly KM; Schwartz CL; Castellanos ME; Dieckmann K; Kluge R; Körholz D
J Clin Oncol; 2015 Sep; 33(27):2975-85. PubMed ID: 26304892
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of CCG 5942: a randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin's lymphoma--a report from the Children's Oncology Group.
Wolden SL; Chen L; Kelly KM; Herzog P; Gilchrist GS; Thomson J; Sposto R; Kadin ME; Hutchinson RJ; Nachman J
J Clin Oncol; 2012 Sep; 30(26):3174-80. PubMed ID: 22649136
[TBL] [Abstract][Full Text] [Related]
14. Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma.
Metzger ML; Weinstein HJ; Hudson MM; Billett AL; Larsen EC; Friedmann A; Howard SC; Donaldson SS; Krasin MJ; Kun LE; Marcus KJ; Yock TI; Tarbell N; Billups CA; Wu J; Link MP
JAMA; 2012 Jun; 307(24):2609-16. PubMed ID: 22735430
[TBL] [Abstract][Full Text] [Related]
15. Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis.
Henderson TO; Parsons SK; Wroblewski KE; Chen L; Hong F; Smith SM; McNeer JL; Advani RH; Gascoyne RD; Constine LS; Horning S; Bartlett NL; Shah B; Connors JM; Leonard JI; Kahl BS; Kelly KM; Schwartz CL; Li H; Friedberg JW; Friedman DL; Gordon LI; Evens AM
Cancer; 2018 Jan; 124(1):136-144. PubMed ID: 28902390
[TBL] [Abstract][Full Text] [Related]
16. Excellent Outcomes Following Response-based Omission of Radiotherapy in Children and Adolescents With Intermediate or High-risk Hodgkin Lymphoma.
Ozuah NW; Marcus KJ; LaCasce AS; Billett AL
J Pediatr Hematol Oncol; 2018 Aug; 40(6):e338-e342. PubMed ID: 29293187
[TBL] [Abstract][Full Text] [Related]
17. Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study.
Castellino SM; Geiger AM; Mertens AC; Leisenring WM; Tooze JA; Goodman P; Stovall M; Robison LL; Hudson MM
Blood; 2011 Feb; 117(6):1806-16. PubMed ID: 21037086
[TBL] [Abstract][Full Text] [Related]
18. Outcome of adolescents and young adults compared to children with Hodgkin lymphoma treated with response-based chemotherapy on pediatric protocols: A Children's Oncology Group report.
Fernández KS; Schwartz CL; Chen L; Constine LS; Chauvenet A; de Alarcón PA
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28612375
[TBL] [Abstract][Full Text] [Related]
19. Childhood Hodgkin International Prognostic Score (CHIPS) Predicts event-free survival in Hodgkin Lymphoma: A Report from the Children's Oncology Group.
Schwartz CL; Chen L; McCarten K; Wolden S; Constine LS; Hutchison RE; de Alarcon PA; Keller FG; Kelly KM; Trippet TA; Voss SD; Friedman DL
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27786406
[TBL] [Abstract][Full Text] [Related]
20. PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
Borchmann P; Goergen H; Kobe C; Lohri A; Greil R; Eichenauer DA; Zijlstra JM; Markova J; Meissner J; Feuring-Buske M; Hüttmann A; Dierlamm J; Soekler M; Beck HJ; Willenbacher W; Ludwig WD; Pabst T; Topp MS; Hitz F; Bentz M; Keller UB; Kühnhardt D; Ostermann H; Schmitz N; Hertenstein B; Aulitzky W; Maschmeyer G; Vieler T; Eich H; Baues C; Stein H; Fuchs M; Kuhnert G; Diehl V; Dietlein M; Engert A
Lancet; 2017 Dec; 390(10114):2790-2802. PubMed ID: 29061295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
